Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $202.30 | Total: $1,011.50 |
| 1 | 10 | $171.36 | Total: $1,713.60 |
| 1 | 25 | $145.18 | Total: $3,629.50 |
| 1 | 50 | $123.76 | Total: $6,188.00 |
| 1 | 100 | $107.10 | Total: $10,710.00 |
Overview
Tanimilast (CHF-6001) is a novel, potent, and selective phosphodiesterase 4 inhibitor with an IC50 value of 0.026
Chemical Properties
| Molecular Formula | C30H30Cl2F2N2O8S |
| Molecular Weight | 687.54 |
| CAS Numbers | 1239278-59-1 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | [C@@H](CC=1C(Cl)=CN(=O)=CC1Cl)(OC(=O)C2=CC(OCC3CC3)=C(NS(C)(=O)=O)C=C2)C4=CC(OCC5CC5)=C(OC(F)F)C=C4 |
Storage and Handling
0C Short Term, -20C Long Term
References
Moretto N, et al. CHF6001 I a novel highly potent and selective phosphodiesterase 4 inhibitor with robust anti-inflammatory activity and suitable for topical pulmonary administration. J Pharmacol Exp Ther. 2015 Mar;352[3] 559-67.